Boston Scientific Corporation

Boston Scientific Corporation

40.59
EUR
+0.44
(+1.10%)
2.08EPS
Feb 03Next Earn

Important Dates

Boston Scientific Corporation's next confirmed earnings release is scheduled for February 3, 2027.

Earnings Date2/3/2027

Share Statistics

As of September 30, 2026, Boston Scientific Corporation has 1.45B shares outstanding.

Shares Outstanding1.45B

Financial Position

As of September 30, 2026, Boston Scientific Corporation maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.20, indicating elevated leverage, while an interest coverage ratio of 14.27 demonstrates strong ability to service its debt obligations.

Current Ratio1.36
Quick Ratio0.62
Debt / Equity46.20
Debt / EBITDA2.23
Interest Coverage14.27

Financial Efficiency

EUR

Over the twelve months ended September 30, 2026, Boston Scientific Corporation posted a return on equity (ROE) of 14.29, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.24 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.94, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.53, useful for judging operating efficiency across full business cycles. The company generates approximately 315,070.83 in revenue per employee across its workforce of 59,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.08 indicates how many times Boston Scientific Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)14.29
Return on Assets (ROA)7.94
Return on Invested Capital (ROIC)10.24
Return on Capital Employed (ROCE)10.53
Revenue Per Employee315,070.83
Employee Count59,000.00
Inventory Turnover2.08

Taxes

EUR

Over the twelve months ended September 30, 2026, Boston Scientific Corporation recorded 142.93M in income tax expense. That works out to an effective tax rate of 4.43, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.22B, leaving 3.09B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax142.93M
Effective Tax Rate4.43

Income Statement

EUR

Over the twelve months ended September 30, 2026, Boston Scientific Corporation generated 18.59B in revenue and converted that into 3.09B in net income, yielding earnings per share of 2.08. EBITDA reached 4.73B, while operating income came in at 3.83B.

Revenue18.59B
Gross Profit12.85B
Operating Income3.83B
Pretax Income3.22B
Net Income3.09B
EBITDA4.73B
EBIT3.47B
Earnings Per Share (EPS)2.08

Balance Sheet

EUR

As of September 30, 2026, Boston Scientific Corporation holds 537.32M in cash and equivalents against 10.55B in total debt, resulting in a net debt position of 9.90B. Total book value stands at 22.61B, with working capital of 1.93B providing operational flexibility.

Cash & Cash Equivalents537.32M
Total Debt10.55B
Net Debt9.90B
Equity (Book Value)22.61B
Book Value Per Share15.60
Working Capital1.93B

Cash Flow

EUR

Boston Scientific Corporation produced 3.74B in operating cash flow over the twelve months ended September 30, 2026. After subtracting -924.65M in capital expenditures, free cash flow totaled 2.81B - equivalent to 1.91 per share.

Operating Cash Flow3.74B
Capital Expenditures-924.65M
Free Cash Flow2.81B
FCF Per Share1.91

Margins

Over the twelve months ended September 30, 2026, Boston Scientific Corporation posted a gross margin of 69.14, reflecting its pricing power and cost economics. The operating margin of 20.59 and net profit margin of 16.62 provide insight into operational efficiency.

Gross Margin69.14
Operating Margin20.59
Pretax Margin17.35
Profit Margin16.62
EBITDA Margin25.46

Stock Splits

Boston Scientific Corporation's most recent stock split took place on November 6, 2003 with a 1:2 split ratio.

Last Split Date11/6/2003
Split Ratio1:2